Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Machine-made humans: a spooky prospect

    White Papers and Resources | September 22, 2015 | Say Communications

    The healthcare team at Saycomms PR asks if major advances in 3D printing and bioprinting could lead to machine-made humans.

    Patient-Centricity: Improving the model with patient journeys

    White Papers and Resources | September 15, 2015 | Blue Latitude Health

    Head of Customer Experience Elisa del Galdo takes us through a better way to look at patient-centricity: with the patient's journey at the centre.

    Four Communications acquires Healthcare specialist MSA Media

    Press Releases | September 9, 2015 | Four Agency Worldwide

    Independent integrated communications agency, Four Communications Group has acquired 100 per cent of market-leading healthcare media planning & buying agency MSA Media.

    The vitamin D deficiency: should we act?

    White Papers and Resources | September 2, 2015 | Say Communications

    Healthcare PR agency Say Communications analyses whether headlines are able to trigger a behavioural change with regards to the vitamin D deficiency issue.

    Is obesity the new smoking?

    White Papers and Resources | September 2, 2015 | Say Communications

    Is obesity the new smoking? The healthcare PR team at Say communications analyses the question posed by NHS Chief executive Simon Stevens.

    Children, the weight issue and how we deal with this responsibly?

    White Papers and Resources | September 2, 2015 | Say Communications

    Say Communication, Healthcare PR Agency, looks at how children deal with the weight issue and how we can approach it responsibly.

    Longevity but at what price?

    White Papers and Resources | September 2, 2015 | Say Communications

    Say Communications, healthcare PR agency, analyses the prospect of living to 150 years old, thanks to the anti-ageing biomedical research, and what PR will look like.

    Competition from within

    White Papers and Resources | August 25, 2015 | Inizio

    Published in eyeforpharma July 29 by Rachel Howard

    Infographic: RA Perceptions

    White Papers and Resources | August 25, 2015 | Inizio

    HCPs predict the future of the biologics market

    From chaos to calm: how to make sense of social media

    White Papers and Resources | August 25, 2015 | Inizio

    What do you know about chaos theory?